scholarly journals 147 TAVI with the Edwards-SAPIEN endoprosthesis: impact of a systematic “oversizing” policy on aortic regurgitation

2011 ◽  
Vol 3 (1) ◽  
pp. 48
Author(s):  
Eric Van Belle ◽  
Mariam Samim ◽  
Pieter Stella ◽  
Jolanda Kluin ◽  
Faiez Ramjankhan ◽  
...  
2013 ◽  
Vol 103 (3) ◽  
pp. 183-190 ◽  
Author(s):  
Patrick Diemert ◽  
Philipp Lange ◽  
Martin Greif ◽  
Moritz Seiffert ◽  
Lenard Conradi ◽  
...  

2017 ◽  
Vol 67 (04) ◽  
pp. 236-242 ◽  
Author(s):  
Kaveh Eghbalzadeh ◽  
Elmar W. Kuhn ◽  
Anton Sabashnikov ◽  
Carolyn Weber ◽  
Parwis Baradaran Rahmanian ◽  
...  

Background The latest generation of balloon-expandable valve, the Edwards Sapien 3 valve (S3V), was designed to reduce paravalvular regurgitation (PVR). We retrospectively compared S3V with Edwards Sapien XT valve (SXTV) with regard to postprocedural transvalvular pressure gradients (PGs). Methods Analysis of 152 patients receiving SXTV and 125 patients receiving S3V between February 2009 and April 2015 was performed. Transvalvular PGs and the incidence and extent of aortic regurgitation (AR) were compared postprocedurally by echocardiography for each valve size. Results Postprocedurally, mean PGs for the 23 mm valves were 10.9 ± 5.3 versus 13.9 ± 5.1 (p = 0.017), whereas maximum PGs were 19.9 ± 8.3 versus 26.1 ± 10.4 mm Hg (p = 0.005) in SXTV and S3V patients, respectively. For the 26 mm valves, gradients were also significantly higher in S3V patients (mean PG: 11.6 ± 4.9 vs. 9.2 ± 4.2 [p = 0.004]; maximum PG: 23.0 ± 10.1 vs. 17.2 ± 7.4 mm Hg [p < 0.001]). Analysis revealed no significant differences in postprocedural transvalvular PGs for 29 mm valves (mean PG of 9.3 ± 3.9 and 11.2 ± 4.3 mm Hg [p = ns] and maximum PG of 17.5 ± 7.2 vs. 20.9 ± 6.8 mm Hg [p = ns]) between SXTV and S3V groups, respectively. With respect to PVR, the incidence of AR was significantly lower in S3V group (p = 0.001). Conclusion S3V shows lower incidence of PVR; however, it is associated with significantly higher postprocedural transvalvular PGs for 23 and 26 mm valve sizes. These data might contribute to the scientific discussion, especially with respect to prosthesis selection in individual patients with small annular dimension.


Open Heart ◽  
2019 ◽  
Vol 6 (1) ◽  
pp. e000976 ◽  
Author(s):  
Paolo Peruzzo ◽  
Francesca Maria Susin ◽  
Andrea Colli ◽  
Gaetano Burriesci

Background and objectiveClinical evaluation of pacing therapy in mitigating the aortic insufficiency after transchateter aortic valve implantation often gives contradictory outcomes. This study presents an in vitro investigation aimed at clarifying the effect of pacing on paravalvular leakage.MethodsA series of in vitro tests reproducing the heart operating changes clinically obtained by pacing was carried out in a 26 mm Edwards Sapien XT prosthesis with mild paravalvular leakage. The effect of pacing on the regurgitant volumes per cycle and per minute was quantified, and the energy and power consumed by the left ventricle were calculated.ResultsResults indicate that though pacing results in some reduction in the total regurgitation per cycle, the volume of fluid regurgitating per minute increases substantially, causing overload of left ventricle.ConclusionsOur tests indicate no effective haemodynamic benefit from pacing, suggesting a prudential clinical use of this therapy for the treatment of postoperative aortic regurgitation.


2015 ◽  
Vol 66 (15) ◽  
pp. B251-B252
Author(s):  
Ramon Rodriguez-Olivares ◽  
Lennart v Gils ◽  
John d Vries ◽  
Sander van Weenen ◽  
Peter De Jaegere ◽  
...  

2013 ◽  
Vol 145 (2) ◽  
pp. 398-405 ◽  
Author(s):  
Mariam Samim ◽  
Pieter R. Stella ◽  
Pierfrancesco Agostoni ◽  
Jolanda Kluin ◽  
Faiz Ramjankhan ◽  
...  

2019 ◽  
Vol 12 (12) ◽  
pp. 1194-1195 ◽  
Author(s):  
Divyanshu Mohananey ◽  
Jyoti Narayanswami ◽  
Arnav Kumar ◽  
Yasser Sammour ◽  
Stephanie Mick ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document